| Literature DB >> 30214366 |
Maurilia Rotolo1,2, Giancarlo Montani2, Raul Martin1,3.
Abstract
BACKGROUND: To determine the peripheral refraction characteristics related to 18-month changes in refraction in Caucasian (Mediterranean) children.Entities:
Keywords: myopia; myopia onset; peripheral refraction; refractive errors; relative peripheral hyperopia
Year: 2017 PMID: 30214366 PMCID: PMC6095563 DOI: 10.2147/OPTO.S134985
Source DB: PubMed Journal: Clin Optom (Auckl) ISSN: 1179-2752
Central and peripheral refraction in all study visits and in each study group
| Group | Field of peripheral refraction | Baseline | 12 months | 18 months |
|---|---|---|---|---|
| All eyes | −30 | 0.12±1.44 (−2.25 to 5.13) | 0.4±1.27 (−1.63 to 5.63) | 0.21±1.26 (−1.5 to 5.5) |
| −20 | 0.11±1.26 (−2.38 to 5.13) | 0.37±1.27 (−2 to 5.38) | 0.20±1.27 (−1.75 to 5.25) | |
| −10 | 0.32±1.18 (−1.25 to 6) | 0.4±1.25 (−2.38 to 5.63) | 0.32±1.34 (−2.63 to 5.88) | |
| 0 | 0.53±1.17 (−1.25 to 5.63) | 0.40±1.28 (−2.75 to 5.63) | 0.41±1.38 (−2.63 to 6) | |
| 10 | 0.32±1.09 (−1.5 to 5.13) | 0.42±1.28 (−2.75 to 6) | 0.31±1.31 (−2.75 to 6.13) | |
| 20 | 0.28±1.14 (−1.63 to 5.5) | 0.31±1.36 (−3.25 to 6.25) | 0.34±1.34 (−3.5 to 6.13) | |
| 30 | 0.19±1.21 (−1.75 to 5.63) | 0.31±1.33 (−3.00 to 6.00) | 0.27±1.36 (−3.13 to 6.38) | |
| nMi-nMf | −30 | 0.43±1.38 (−2.25 to 5.13) | 0.69±1.28 (−1.00 to 5.63) | 0.53±1.26 (−1.38 to 5.5) |
| −20 | 0.40±1.20 (−1.13 to 5.13) | 0.66±1.26 (−1.25 to 5.38) | 0.52±1.27 (−1.25 to 5.25) | |
| −10 | 0.54±1.23 (−1.25 to 6.00) | 0.71±1.20 (−0.63 to 5.63) | 0.63±1.33 (−0.75 to 5.88) | |
| 0 | 0.84±1.15 (−0.38 to 5.63) | 0.73±1.23 (−0.63 to 5.63) | 0.76±1.30 (−0.38 to 6.00) | |
| 10 | 0.53±1.15 (−0.88 to 5.13) | 0.69±1.26 (−0.75 to 6.00) | 0.61±1.28 (−0.63 to 6.13) | |
| 20 | 0.53±1.17 (−1.50 to 5.50) | 0.61±1.31 (−1.25 to 6.25) | 0.65±1.30 (−0.63 to 6.13) | |
| 30 | 0.42±1.25 (−1.25 to 5.63) | 0.64±1.28 (−1.5 to 6.00) | 0.57±1.35 (−0.75 to 6.38) | |
| nMi-Mf | −30 | −0.33±2.08 (−2.25 to 1.88) | −0.79±0.76 (−1.63 to −0.13) | −0.54±0.31 (−0.88 to −0.25) |
| −20 | −0.13±1.42 (−1.13 to 1.5) | −0.17±0.95 (−1 to 0.88) | −0.75±0.66 (−1.5 to −0.25) | |
| −10 | 0.33±0.40 (−0.13 to 0.63) | −0.67±0.19 (−0.88 to −0.50) | −0.25±0.25 (−0.50 to 0.00) | |
| 0 | 0.21±0.14 (0.13 to 0.38) | −0.17±0.14 (−0.25 to 0.00) | −0.63±0.13 (−0.75 to −0.50) | |
| 10 | −0.08±0.29 (−0.25 to 0.25) | −0.04±0.31 (−0.38 to 0.25) | −0.42±0.19 (−0.63 to −0.25) | |
| 20 | −0.29±0.38 (−0.63 to 0.13) | −0.83±0.29 (−1.00 to −0.50) | −0.21±0.38 (−0.63 to 0.13) | |
| 30 | −0.25±0.33 (−0.63 to 0.00) | −0.79±0.40 (−1.25 to −0.50) | −0.42±0.44 (−0.88 to 0.00) | |
| Mi-Mf | −30 | −0.79±0.89 (−1.75 to 0.63) | −0.58±0.75 (−1.50 to 0.25) | −1.10±0.43 (−1.50 to −0.38) |
| −20 | −0.83±0.75 (−1.88 to 0.25) | −1.02±0.70 (−2.00 to −0.25) | −1.10±0.52 (−1.75 to −0.38) | |
| −10 | −0.67±0.37 (−1.00 to 0.00) | −0.90±0.91 (−2.38 to −0.13) | −1.19±0.79 (−2.63 to −0.38) | |
| 0 | −0.79±0.30 (−1.25 to −0.50) | −1.17±0.84 (−2.75 to −0.50) | −1.27±0.75 (−2.63 to −0.50) | |
| 10 | −0.52±0.53 (−1.50 to 0.00) | −0.94±0.95 (−2.75 to −0.25) | −1.08±1.02 (−2.75 to 0.13) | |
| 20 | −0.71±0.73 (−1.63 to 0.50) | −0.96±1.28 (−3.25 to 0.00) | −1.08±1.26 (−3.5 to 0.13) | |
| 30 | −0.85±0.81 (−1.75 to 0.25) | −0.90±1.18 (−3.00 to 0.38) | −1.06±1.13 (−3.13 to 0.00) |
Note: Data presented as mean ± SD (95% CI).
Abbreviations: Mi-Mf, myopic during the 18 months; nMi-Mf, non-myopic at baseline and developed myopia after 18 months; nMi-nMf, non-myopic after 18 months.
Figure 1Peripheral refraction (A) and relative peripheral refraction (B) for the children in the “nonmyopia, myopia” classification at baseline (left), at 12 months (middle), and at 18 months (right).
Notes: Plotted after univariate analysis of variance. (A) Central and peripheral refraction: statistically significant differences were found between groups (F2=73.21; P<0.01). However, there were nonsignificant differences between visits (F2=0.08; P=0.92) and visual field angle (F6=0.47; P=0.83) in refraction. (B) RPR: statistically significant differences were found between groups (F2=13.61; P<0.01), visits (F2=3.92; P=0.02), and visual field angle (F6=2.86; P=0.01). However, the interaction between visits and RPR was statistically nonsignificant between groups (F36=0.79; P=0.80).
Abbreviations: RPR, relative peripheral refraction; nMi-nMf, non-myopic after 18 months; nMi-Mf, non-myopic at baseline and developed myopia after 18 months; Mi-Mf, myopic during the 18 months.
Relative peripheral refraction in all study visits and in each study group
| Group | Field of peripheral refraction | Baseline | 12 months | 18 months |
|---|---|---|---|---|
| All eyes | −30 | −0.41±0.78 (−2.63 to 1.5) | −0.01±0.56 (−1.63 to 1.25) | −0.2±0.53 (−1.5 to 1.13) |
| −20 | −0.42±0.59 (−1.88 to 1.13) | −0.03±0.49 (−1.88 to 0.88) | −0.21±0.48 (−1.38 to 0.88) | |
| −10 | −0.21±0.42 (−1.25 to 0.5) | −0.01±0.5 (−1.25 to 2) | −0.08±0.39 (−1.5 to 0.63) | |
| 10 | −0.21±0.53 (−1.25 to 0.88) | 0.02±0.45 (−1 to 1) | −0.1±0.45 (−1.38 to 1.13) | |
| 20 | −0.25±0.55 (−2 to 1) | −0.09±0.54 (−1.13 to 1.13) | −0.07±0.5 (−1.5 to 1.13) | |
| 30 | −0.34±0.6 (−2.13 to 0.88) | −0.1±0.58 (−1.63 to 1.38) | −0.14±0.54 (−1.63 to 1) | |
| nMi-nMf | −30 | −0.41±0.68 (−2.63 to 0.75) | −0.04±0.51 (−1.63 to 1.13) | −0.23±0.52 (−1.5 to 0.63) |
| −20 | −0.44±0.5 (−1.5 to 0.63) | −0.07±0.49 (−1.88 to 0.63) | −0.24±0.46 (−1.38 to 0.75) | |
| −10 | −0.3±0.41 (−1.25 to 0.38) | −0.02±0.51 (−1.25 to 2) | −0.13±0.41 (−1.5 to 0.63) | |
| 10 | −0.31±0.51 (−1.25 to 0.88) | −0.04±0.46 (−1 to 1) | −0.15±0.43 (−1.38 to 0.75) | |
| 20 | −0.32±0.54 (−2 to 1) | −0.12±0.52 (−1.13 to 1.13) | −0.12±0.41 (−1.5 to 0.5) | |
| 30 | −0.42±0.59 (−2.13 to 0.88) | −0.09±0.57 (−1.63 to 1) | −0.2±0.49 (−1.63 to 1) | |
| nMi-Mf | −30 | −0.54±1.95 (−2.38 to 1.5) | −0.63±0.75 (−1.38 to 0.13) | 0.08±0.19 (−0.13 to 0.25) |
| −20 | −0.33±1.28 (−1.25 to 1.13) | 0±0.82 (−0.75 to 0.88) | −0.13±0.54 (−0.75 to 0.25) | |
| −10 | 0.13±0.38 (−0.25 to 0.5) | −0.5±0.22 (−0.63 to −0.25) | 0.38±0.13 (0.25 to 0.5) | |
| 10 | −0.29±0.38 (−0.63 to 0.13) | 0.13±0.33 (−0.13 to 0.5) | 0.21±0.26 (0 to 0.5) | |
| 20 | −0.5±0.5 (−1 to 0) | −0.67±0.38 (−1 to −0.25) | 0.42±0.36 (0 to 0.63) | |
| 30 | −0.46±0.47 (−1 to −0.13) | −0.63±0.54 (−1.25 to −0.25) | 0.21±0.4 (−0.25 to 0.5) | |
| Mi-Mf | −30 | 0±0.66 (−0.75 to 1.13) | 0.58±0.52 (−0.25 to 1.25) | 0.17±0.55 (−0.5 to 1.13) |
| −20 | −0.04±0.54 (−0.88 to 0.75) | 0.15±0.46 (−0.63 to 0.75) | 0.17±0.45 (−0.5 to 0.88) | |
| −10 | 0.13±0.38 (−0.5 to 0.5) | 0.27±0.38 (−0.25 to 0.88) | 0.08±0.19 (−0.25 to 0.25) | |
| 10 | 0.27±0.43 (−0.5 to 0.63) | 0.23±0.32 (0 to 0.75) | 0.19±0.57 (−0.5 to 1.13) | |
| 20 | 0.08±0.55 (−0.63 to 1) | 0.21±0.56 (−0.5 to 1) | 0.19±0.74 (−0.88 to 1.13) | |
| 30 | −0.06±0.62 (−0.75 to 0.75) | 0.27±0.57 (−0.25 to 1.38) | 0.21±0.68 (−0.75 to 1) |
Note: Data presented as mean ± SD (95% CI).
Abbreviations: Mi-Mf, myopic during the 18 months; nMi-Mf, non-myopic at baseline and developed myopia after 18 months; nMi-nMf, non-myopic after 18 months.
Figure 2Axial length in all study visits and in each study group.
Abbreviations: nMi-nMf, non-myopic after 18 months; nMi-Mf, non-myopic at baseline and developed myopia after 18 months; Mi-Mf, myopic during the 18 months.